CHRNA7 and hepatocellular carcinoma: HCC patients with high α7-nAChR expression were 2-fold more likely to experience recurrence (95% confidence interval (CI), 1.08–4.21; p = 0.001) than were patients with low α7-nAChR expression (Table 2).